Long noncoding RNAs in hepatitis B virus replication and oncogenesis

doi:10.3748/wjg.v28.i25.2823

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5260)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

254

WORD

HTML

2840

Figures (1-3)

685

Tables (1-2)

388

Sum=4238

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

367

Download

655

Sum=1022

Jul 7, 2022 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 7, 2022; 28(25): 2823-2842
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2823

Long noncoding RNAs in hepatitis B virus replication and oncogenesis

Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo

Hui-Chun Li, Department of Biochemistry, Tzu Chi University, Hualien 97004, Taiwan

Chee-Hing Yang, Shih-Yen Lo, Department of Laboratory Medicine and Biotechnology, Tzu Chi University, Hualien 97004, Taiwan

Shih-Yen Lo, Department of Laboratory Medicine, Buddhist Tzu Chi General Hospital, Hualien 97004, Taiwan

Author contributions: Li HC and Lo SY wrote the manuscript; Yang CH and Lo SY drew the figures.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Shih-Yen Lo, PhD, Professor, Department of Laboratory Medicine and Biotechnology, Tzu Chi University, No. 701 Section 3, Chung Yang Road, Hualien 97004, Taiwan. losylo@mail.tcu.edu.tw

Received: January 16, 2022
Peer-review started: January 16, 2022
First decision: April 11, 2022
Revised: April 16, 2022
Accepted: May 21, 2022
Article in press: May 21, 2022
Published online: July 7, 2022
Processing time: 168 Days and 20 Hours

Core Tip

Core Tip: The prognosis of hepatocellular carcinoma (HCC) remains poor. It is important to identify novel tumor markers for early diagnosis and find more therapeutic targets for effective treatments of HCC. Several diverse long noncoding RNAs (lncRNAs) have been identified to be involved in hepatitis B virus (HBV)-related HCC. A better understanding of the molecular mechanisms underlying lncRNA-mediated hepatocarcinogenesis may help for their use in early diagnosis and to identify appropriate targets for the prevention and treatment of HBV-related HCC.